1. 2019
  2. Cell Mass Increase Associated with Formation of Glucose-Controlling β-Cell Mass in Device-Encapsulated Implants of hiPS-Derived Pancreatic Endoderm

    Robert, T., De Mesmaeker, I., Van Hulle, F. O., Suenens, K. G., Stangé, G. M., Ling, Z., Haller, C., Bouche, N., Keymeulen, B., Kraus, M. R. C. & Pipeleers, D. G., 4 Aug 2019, In : Stem Cells Translational Medicine.

    Research output: Contribution to journalArticleResearchpeer-review

  3. Intrathyroidal parathyroid carcinoma presenting as an asymptomatic hypercalcemia: a case report

    Poortmans, N., Verfaillie, G., Unuane, D., Raeymaeckers, S. & Lamote, J., 21 Jun 2019, In : Acta Chirurgica Belgica. 2019, p. 1-4 4 p.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Long-Term Treatment with Calcitriol in Postsurgical Hypoparathyroidism Leads to Renal Function Decline

    Coudenys, E., Meerhaeghe, T. V., Unuane, D., Buyl, R. & Bravenboer, B., Jun 2019, In : Hormone and Metabolic Research. 51, 6, p. 362-366 5 p.

    Research output: Contribution to journalArticleResearchpeer-review

  5. A Specific CNOT1 Mutation Results in a Novel Syndrome of Pancreatic Agenesis and Holoprosencephaly through Impaired Pancreatic and Neurological Development

    De Franco, E., Watson, R. A., Weninger, W. J., Wong, C. C., Flanagan, S. E., Caswell, R., Green, A., Tudor, C., Lelliott, C. J., Geyer, S. H., Maurer-Gesek, B., Reissig, L. F., Lango Allen, H., Caliebe, A., Siebert, R., Holterhus, P. M., Deeb, A., Prin, F., Hilbrands, R., Heimberg, H. & 3 othersEllard, S., Hattersley, A. T. & Barroso, I., 2 May 2019, In : American Journal of Human Genetics. 104, 5, p. 985-989 5 p.

    Research output: Contribution to journalArticleResearchpeer-review

  6. Unidentified cachexia patients in the oncologic setting: Cachexia UFOs do exist

    De Waele, E., Demol, J., Caccialanza, R., Cotogni, P., Spapen, H., Malbrain, M. L., De Grève, J. & Pen, J. J., 28 Apr 2019, In : Nutrition. 63-64, p. 200-204 5 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. Target engagement and cellular fate of otelixizumab; a repeat dose escalation study of an anti-CD3ε mAb in New-Onset Type 1 Diabetes Mellitus Patients

    Vlasakakis, G., Napolitano, A., Barnard, R., Brown, K., Bullman, J., Inman, D., Keymeulen, B., Lanham, D., Leirens, Q., MacDonald, A., Mezzalana, E., Page, K., Patel, M., Savage, C. O., Zamuner, S. & van Maurik, A., Apr 2019, In : British Journal of Clinical Pharmacology. 85, 4, p. 704-714 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. Pancreatic Islet Isolation from Donors after Controlled Circulatory Death

    De Paep, D. L., Ling, Z., Vanhoeij, M., Pirenne, J., Lamote, J. & Jacobs-Tulleneers-Thevissen, D., 14 Mar 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  9. Pancreatic Islet Isolation from Donors after Euthanasia

    De Paep, D. L., Ling, Z., Ysebaert, D., Poelaert, J., Vanhoeij, M., Lamote, J. & Jacobs-Tulleneers-Thevissen, D., 14 Mar 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  10. Glucocorticoids and checkpoint tyrosine kinase inhibitors stimulate rat pancreatic beta cell proliferation differentially

    Akbib, S., Stichelmans, J., Stangé, G., Ling, Z., Assefa, Z. & Hellemans, K. H., 19 Feb 2019, In : PLoS ONE. 14, 2, 20 p., e0212210.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next

ID: 36387468